Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Ordinary shares, par value of NIS 0.00001 per share
Symbol
CLBT on Nasdaq
Shares outstanding
248,571,184
Price per share
$18.06
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
129,203,829
Total reported value
$2,327,514,699
% of total 13F portfolios
0.02%
Share change
+701,674
Value change
+$10,999,665
Number of holders
209
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUNCORPORATION 43% -2.3% $1,915,539,751 +$63,014,988 106,065,324 +3.4% SUNCORPORATION 31 Dec 2025
TWC Tech Holdings II, LLC 6.1% $294,700,753 14,661,729 Adam H. Clammer 18 Mar 2025
FMR LLC 4.1% -22% $199,496,862 -$13,992,153 9,925,217 -6.6% FMR LLC 31 Mar 2025

As of 31 Dec 2025, 209 institutional investors reported holding 129,203,829 shares of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT). This represents 52% of the company’s total 248,571,184 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) together control 38% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
True Wind Capital Management, L.P. 5.6% 13,861,007 0% 96% $249,913,956
FMR LLC 3.8% 9,347,182 +54% 0.01% $168,529,699
T. Rowe Price Investment Management, Inc. 3.4% 8,514,894 -15% 0.1% $153,524,000
Voss Capital, LP 3.2% 8,050,000 +19% 7.7% $145,141,500
Pertento Partners LLP 2.4% 5,959,324 +28% 12% $107,446,612
Invesco Ltd. 2.3% 5,603,237 +0.77% 0.02% $101,026,363
BlackRock, Inc. 1.7% 4,328,913 +16% 0% $78,050,301
Clal Insurance Enterprises Holdings Ltd 1.4% 3,473,014 -11% 0.4% $62,618,000
Granahan Investment Management, LLC 1.2% 3,057,018 +16% 2.4% $55,118,035
Phoenix Financial Ltd. 1% 2,510,774 +0.15% 0.49% $45,267,596
RENAISSANCE TECHNOLOGIES LLC 1% 2,494,939 -14% 0.07% $44,983,750
Nine Ten Capital Management LLC 1% 2,479,727 0% 14% $44,709,000
Capital Research Global Investors 0.97% 2,405,172 -0.85% 0.01% $43,365,251
COOPER CREEK PARTNERS MANAGEMENT LLC 0.96% 2,395,973 -21% 2% $43,199,000
MORGAN STANLEY 0.96% 2,390,114 -17% 0% $43,093,756
Nuveen, LLC 0.92% 2,279,640 +6% 0.01% $41,101,910
Capital International Investors 0.92% 2,278,040 0.01% $41,073,061
ASHFORD CAPITAL MANAGEMENT INC 0.67% 1,670,845 -1.7% 3.4% $30,125,335
PRINCIPAL FINANCIAL GROUP INC 0.65% 1,610,832 -2.8% 0.01% $29,043,301
Greenhaven Road Investment Management, L.P. 0.64% 1,599,937 -3.2% 12% $28,846,864
Handelsbanken Fonder AB 0.61% 1,510,000 -48% 0.08% $27,225,000
AXON ENTERPRISE, INC. 0.61% 1,509,341 -59% 100% $27,213,418
MEITAV INVESTMENT HOUSE LTD 0.59% 1,454,846 0% 0.32% $26,230,873
RAYMOND JAMES FINANCIAL INC 0.58% 1,453,096 -2.9% 0.01% $26,144,060
Artisan Partners Limited Partnership 0.58% 1,434,888 0.04% $25,871,031

Institutional Holders of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 129,203,829 $2,327,514,699 +$10,999,665 $18.03 209
2025 Q3 129,479,868 $2,399,228,901 +$236,282,955 $18.53 196
2025 Q2 118,023,067 $1,888,023,265 +$96,376,127 $16.00 207
2025 Q1 111,091,356 $2,158,060,728 +$17,336,152 $19.43 196
2024 Q4 109,611,642 $2,414,743,153 +$172,628,937 $22.03 190
2024 Q3 92,027,552 $1,549,738,036 +$162,565,361 $16.84 162
2024 Q2 82,827,477 $989,795,174 +$84,273,008 $11.95 146
2024 Q1 75,864,626 $836,285,496 +$117,532,707 $11.08 138
2023 Q4 86,517,854 $748,725,177 +$75,873,899 $8.66 116
2023 Q3 53,304,550 $402,692,089 +$106,109,469 $7.65 93
2023 Q2 38,873,021 $279,822,194 +$12,002,094 $7.20 75
2023 Q1 37,362,412 $227,499,632 +$5,419,519 $6.09 57
2022 Q4 40,117,660 $174,910,523 -$3,630,060 $4.36 51
2022 Q3 41,084,252 $161,537,648 +$10,182,285 $3.92 43
2022 Q2 38,483,927 $196,125,190 -$3,326,950 $5.10 45
2022 Q1 38,618,479 $247,169,160 +$8,435,170 $6.40 49
2021 Q4 36,614,332 $293,619,620 +$8,905,659 $8.02 48
2021 Q3 21,734,465 $200,833,000 +$200,767,000 $9.26 25